SCHEMBL3278335

SCHEMBL3278335

c1ccc(CO[C]2CCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
MAOB P27338 5/20 0.47
BCHE P06276 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
CYP2C19 P33261 1/20 0.47
PTGS2 P35354 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HIF1A Q16665 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
MAPT P10636 3/20 0.45
MAOA P21397 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
GAA P10253 2/20 0.45
RAB9A P51151 2/20 0.45
APP P05067 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061320 0.98 TSHR (0.46) TSHRMAOBBCHELMNACYP1A2
SCHEMBL3660167 0.95 TSHR (0.48) TSHRMAOBBCHELMNACYP1A2
SCHEMBL6469379 0.91 TSHR (0.52) TSHRMAOBBCHELMNACYP1A2
SCHEMBL17597872 0.77 FFAR1 (0.51) BCHETDP1
SCHEMBL11154487 0.74 L3MBTL1 (0.47) TSHRMAOBBCHELMNACYP1A2
SCHEMBL6433409 0.74 HTT (0.44) TSHRMAOBBCHELMNACYP1A2
Benzylphenylether SCHEMBL28158791 0.72 MAPT (0.55) MAOBBCHELMNACYP1A2PTGS1
SCHEMBL10609652 0.71 LMNA (0.75) MAOBBCHELMNACYP1A2PTGS1
SCHEMBL6210880 0.71 LMNA (0.55) MAOBBCHELMNACYP1A2PTGS1
SCHEMBL30299191 0.71 HRH3 (0.72) MAOBHRH3MAPTMAOAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696181-B2 Partial and full agonists of A1 adenosine receptors CV THERAPEUTICS, INC. (US) 2010-04-13 US claimed
EP-3172211-A1 COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-05-31 EP disclosed
WO-2016011930-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-01-28 WO disclosed
CN-102105451-B Glucokinase activators TAKEDA SAN DIEGO INC 2013-11-13 CN disclosed
JP-2008019351-A METHOD FOR SEPARATING OPTICALLY ACTIVE N-SUBSTITUTED HOMOPHENYLALANINE TOSOH CORP 2008-01-31 JP disclosed